Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing
Benzinga
APRIL 8, 2024
The asset platform includes two formulations: VAR-101 (topical) and VAR-102 (oral). Protein kinase inhibitors are a class of anti-cancer therapeutics that have made a significant impact on the treatment of cancers.
Let's personalize your content